Epigenetics for Drug Discovery
About this book
Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company and a substantial number of biotechnology companies targeting epigenetic processes to treat diseases ranging from cancer to Huntington's disease and from inflammation to sickle cell anaemia.
The book is structured in three main sections. The first section introduces epigenetics and explain its importance at both a phenomenological and molecular level. The second section goes on to review how each of the big breakthroughs in drug discovery in this field have developed, with a strong emphasis on case histories. The final section highlights the ongoing challenges in creating safe and efficacious epigenetic drugs.
Written and edited by experts within the field from both industry and academia, this book provides an invaluable guide to this developing field for medicinal chemists working in academia and in the pharmaceutical industry.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Epigenetics for Drug Discovery
- Preface
- Contents
- Chapter 1 - Epigenetics – What it is and Why it Matters
- Chapter 2 - Enzyme and Protein Families that Regulate Histone Modifications and Crosstalk
- Chapter 3 - Epigenetics and Disease
- Chapter 4 - Targeting DNA Methylation
- Chapter 5 - Targeting Histone Acetylation
- Chapter 6 - Targeting Histone Lysine Methyltransferases in Cancer
- Chapter 7 - Targeting Non-Acetylation Histone Erasers
- Chapter 8 - Progress in Targeting Epigenetic Readers
- Chapter 9 - Who will Benefit from Epigenetic Drugs
- Chapter 10 - Dosing – When Less is More
- Chapter 11 - Histone Methyltransferase Activity Assays
- Chapter 12 - Safety Considerations for Epigenetic Mechanisms as Drug Targets: Are Existing Toxicology Studies Fit for Purpose
- Subject Index
